Development and Validation of a Quantitative Polymerase Chain Reaction Assay to Evaluate Minimal Residual Disease for T-Cell Acute Lymphoblastic Leukemia and Follicular Lymphoma

American Journal of Pathology- United States

doi 10.1016/s0002-9440(10)65355-2

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV


Related search